Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
Sarcoma Oncology Research Center, LLC
Stanford University
Pfizer
Albert Einstein College of Medicine
Hoffmann-La Roche
City of Hope Medical Center
Nektar Therapeutics
Dana-Farber Cancer Institute
Virginia Commonwealth University
Stanford University
Pfizer
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
GE Healthcare
INSYS Therapeutics Inc